Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors

GLIA

Volumn 65, Issue 7, 2017, Pages 1119-1136

  O'Sullivan, Sinead A ^a   Velasco Estevez, Maria ^a   Dev, Kumlesh K ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

catalase; cerebellar slices; glucose oxidase; low continuous H2O2, pFTY720

Indexed keywords

CATALASE; FINGOLIMOD; FRACTALKINE; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN 6; IONIZED CALCIUM BINDING ADAPTER MOLECULE 1; MYELIN BASIC PROTEIN; NEUROFILAMENT H; NEUROFILAMENT PROTEIN; PROTEIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN; AIF1 PROTEIN, HUMAN; DNA BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; MYEF2 PROTEIN, ZEBRAFISH; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROFILAMENT PROTEIN H; REPRESSOR PROTEIN; ZEBRAFISH PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CEREBELLAR SLICE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEMYELINATION; DILUTION; FETUS; FLUORESCENCE; GLIAL CELL CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NERVE FIBER TRANSPORT; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; SLICE CULTURE; WESTERN BLOTTING; WHITE MATTER; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CEREBELLUM; CYTOLOGY; DEMYELINATING DISEASE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; CELLS, CULTURED; CEREBELLUM; DEMYELINATING DISEASES; DNA-BINDING PROTEINS; FEMALE; FETUS; FINGOLIMOD HYDROCHLORIDE; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROFILAMENT PROTEINS; OXIDATIVE STRESS; RECEPTORS, LYSOSPHINGOLIPID; REPRESSOR PROTEINS; ZEBRAFISH PROTEINS;

EID: 85017366905     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23148     Document Type: Article

References (87)

1. Alim, I., Haskew-Layton, R. E., Aleyasin, H., Guo, H., & Ratan, R. R. (2014). Spatial, temporal, and quantitative manipulation of intracellular hydrogen peroxide in cultured cells. Methods in Enzymology, 547, 251–273.
2. Aydin, O., Ellidag, H. Y., Eren, E., Kurtulus, F., Yaman, A., & Yilmaz, N. (2014). Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis. Biochemia Medica (Zagreb), 24, 383–389.
3. Bae, Y. S., Kang, S. W., Seo, M. S., Baines, I. C., Tekle, E., Chock, P. B., & Rhee, S. G. (1997). Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. Journal of Biological Chemistry, 272, 217–221.
4. Barateiro, A., Brites, D., & Fernandes, A. (2016). Oligodendrocyte development and myelination in neurodevelopment: Molecular mechanisms in health and disease. Current Pharmaceutical Design, 22, 656–679.
5. Barth, B. M., Gustafson, S. J., & Kuhn, T. B. (2012). Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. Journal of Neuroscience Research, 90, 229–242.
6. Bienert, G. P, Schjoerring, J. K., & Jahn, T. P. (2006). Membrane transport of hydrogen peroxide. Biochimica et Biophysica Acta, 1758, 994–1003.
7. Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015). Oxidative stress and Parkinson's disease. Frontiers in Neuroanatomy, 9, 91–100.
8. Boche, D., Perry, V. H., & Nicoll, J. A. (2013). Review: Activation patterns of microglia and their identification in the human brain. Neuropathology and Applied Neurobiology, 39, 3–18.
9. Boveris, A., Oshino, N., & Chance, B. (1972). The cellular production of hydrogen peroxide. Biochemical Journal, 128, 617–630.
10. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., … Lynch, K. R. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. Journal of Biological Chemistry, 277, 21453–21457.
11. Carri, M. T., Valle, C., Bozzo, F., & Cozzolino, M. (2015). Oxidative stress and mitochondrial damage: Importance in non-SOD1 ALS. Frontiers in Cellular Neuroscience, 9, 41–47.
12. Choi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C. W., Noguchi, K., … Chun, J. (2011). FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proceedings of the National Academy Sciences of the United States of America, 108, 751–756.
13. Colombo, E., Di Dario, M., Capitolo, E., Chaabane, L., Newcombe, J., Martino, G., & Farina, C. (2014). Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide. Annals of Neurology, 76, 325–337.
14. Desagher, S., Glowinski, J., & Premont, J. (1996). Astrocytes protect neurons from hydrogen peroxide toxicity. Journal of Neuroscience, 16, 2553–2562.
15. Dev, K. K., Mullershausen, F., Mattes, H., Kuhn, R. R., Bilbe, G., Hoyer, D., & Mir, A. (2008). Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis. Pharmacology & Therapeutics, 117, 77–93.
16. di Penta, A., Moreno, B., Reix, S., Fernandez-Diez, B., Villanueva, M., Errea, O., … Villoslada, P. (2013). Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One, 8, e54722.
17. Do, K. Q., Cuenod, M., & Hensch, T. K. (2015). Targeting oxidative stress and aberrant critical period plasticity in the developmental trajectory to schizophrenia. Schizophrenia Bulletin, 41, 835–846.
18. Doi, Y., Takeuchi, H., Horiuchi, H., Hanyu, T., Kawanokuchi, J., Jin, S., … Suzumura, A. (2013). Fingolimod phosphate attenuates oligomeric amyloid beta-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons. PLoS One, 8, e61988.
19. Dringen, R., & Hamprecht, B. (1997). Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Research, 759, 67–75.
20. Dringen, R., Pawlowski, P. G., & Hirrlinger, J. (2005). Peroxide detoxification by brain cells. Journal of Neuroscience Research, 79, 157–165.
21. Edsall, L. C., Pirianov, G. G., & Spiegel, S. (1997). Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. Journal of Neuroscience, 17, 6952–6960.
22. Elain, G., Jeanneau, K., Rutkowska, A., Mir, A. K., & Dev, K. K. (2014). The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes. Glia, 62,725–735.
23. Feeney, C. J., Frantseva, M. V., Carlen, P. L., Pennefather, P. S., Shulyakova, N., Shniffer, C., & Mills, R. (2008). Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices. Brain Research, 1198, 1–15.
24. Fernandez-Gamba, A., Leal, M. C., Maarouf, C. L., Richter-Landsberg, C., Wu, T., Morelli, L., … Castano, E. M. (2012). Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress. Journal of Neurochemistry, 121, 985–995.
25. Filiou, M. D., Teplytska, L., Otte, D. M., Zimmer, A., & Turck, C. W. (2012). Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. Journal of Psychiatric Research, 46, 1359–1365.
26. Fukumoto, K., Mizoguchi, H., Takeuchi, H., Horiuchi, H., Kawanokuchi, J., Jin, S., … Suzumura, A. (2014). Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid beta-induced memory impairment. Behavioural Brain Research, 268, 88–93.
27. Gille, J. J., & Joenje, H. (1992). Cell culture models for oxidative stress: Superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutation Research, 275, 405–414.
28. Giralt, M., Ramos, R., Quintana, A., Ferrer, B., Erta, M., Castro-Freire, M., … Hidalgo, J. (2013). Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6. Glia, 61, 587–600.
29. Gruber, R. C., LaRocca, D., Minchenberg, S. B., Christophi, G. P., Hudson, C. A., Ray, A. K., … Masa, P. T. (2015). The control of reactive oxygen species production by SHP-1 in oligodendrocytes. Glia, 63, 1753–1771.
30. Hagen, N., Van Veldhoven, P. P., Proia, R. L., Park, H., Merrill, A. H. Jr., & van Echten-Deckert, G. (2009). Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. Journal of Biological Chemistry, 284, 11346–11353.
31. Halliwell, B. (1992). Reactive oxygen species and the central nervous system. Journal of Neurochemistry, 59, 1609–1623.
32. Healy, L. M., Sheridan, G. K., Pritchard, A. J., Rutkowska, A., Mullershausen, F., & Dev, K. K. (2013). Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes. British Journal of Pharmacology, 169, 1114–1129.
33. Heimfarth, L., Loureiro, S. O., Dutra, M. F., Petenuzzo, L., de Lima, B. O., Fernandes, C. G., … Pessoa-Pureur, R. (2013). Disrupted cytoskeletal homeostasis, astrogliosis and apoptotic cell death in the cerebellum of preweaning rats injected with diphenyl ditelluride. Neurotoxicology, 34, 175–188.
34. Hernandez, O. M., Discher, D. J., Bishopric, N. H., & Webster, K. A. (2000). Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Circulation Research, 86, 198–204.
35. 2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells. Antioxidants & Redox Signaling, 18, 1895–1905.
36. Ito, J. I., Nagayasu, Y., Ogawa, T., Okihara, H., & Michikawa, M. (2015). Biochemical properties in membrane of rat astrocytes under oxidative stress. Brain Research, 1615, 1–11.
37. Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., … Radue, E. W. (2006). Oral fingolimod (FTY720) for relapsing multiple sclerosis. New England Journal of Medicine, 355, 1124–1140.
38. Karlik, M., Valkovic, P., Hancinova, V., Krizova, L., Tothova, L., & Celec, P. (2015). Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis. Clinical Biochemistry, 48, 24–28.
39. Kobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., … Yamamoto, M. (2009). The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Molecular and Cellular Biology, 29, 493–502.
40. Lee, D. H., Gold, R., & Linker, R. A. (2012). Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: Therapeutic modulation via fumaric acid esters. International Journal of Molecular Sciences, 13, 11783–11803.
41. Lee, J. C., & Won, M. H. (2014). Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils. Anatomy & Cell Biology, 47, 149–156.
42. Lee, J. P., Cha, H. J., Lee, K. S., Lee, K. K., Son, J. H., Kim, K. N., … An, S. (2012). Phytosphingosine-1-phosphate represses the hydrogen peroxide-induced activation of c-Jun N-terminal kinase in human dermal fibroblasts through the phosphatidylinositol 3-kinase/Akt pathway. Archives of Dermatological Research, 304, 673–678.
43. Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., … Barres, B. A. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 541, 481–487.
44. Liu, H., Toman, R. E., Goparaju, S. K., Maceyka, M., Nava, V. E., Sankala, H., … Spiegel, S. (2003). Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. Journal of Biological Chemistry, 278, 40330–40336.
45. Lo, Y. Y., & Cruz, T. F. (1995). Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. Journal of Biological Chemistry, 270, 11727–11730.
46. 2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells. Asian Pacific Journal of Cancer Prevention, 16, 1637–1642.
47. Maceyka, M., Milstien, S., & Spiegel, S. (2007). Shooting the messenger: Oxidative stress regulates sphingosine-1-phosphate. Circulation Research, 100, 7–9.
48. Marinho, H. S., Real, C., Cyrne, L., Soares, H., & Antunes, F. (2014). Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biology, 2, 535–562.
49. Mattes, H., Dev, K. K., Bouhelal, R., Barske, C., Gasparini, F., Guerini, D., … Haessig, S. (2010). Design and synthesis of selective and potent orally active S1P5 agonists. ChemMedChem, 5, 1693–1696.
50. May, J. M., & de Haen, C. (1979). Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. Journal of Biological Chemistry, 254, 2214–2220.
51. 2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). Journal of Biological Chemistry, 287, 37472–37482.
52. Milosevic, A., & Zecevic, N. (1998). Developmental changes in human cerebellum: Expression of intracellular calcium receptors, calcium-binding proteins, and phosphorylated and nonphosphorylated neurofilament protein. Journal of Comparative Neurology, 396, 442–460.
53. Milton, N. G. (2004). Role of hydrogen peroxide in the aetiology of Alzheimer's disease: Implications for treatment. Drugs & Aging, 21, 81–100.
54. Miron, V. E., Jung, C. G., Kim, H. J., Kennedy, T. E., Soliven, B., & Antel, J. P. (2008). FTY720 modulates human oligodendrocyte progenitor process extension and survival. Annals of Neurology, 63, 61–71.
55. Miron, V. E, Kuhlmann, T., & Antel, J. P. (2011). Cells of the oligodendroglial lineage, myelination, and remyelination. Biochimica et Biophysica Acta, 1812, 184–193.
56. Miron, V. E., Ludwin, S. K., Darlington, P. J., Jarjour, A. A., Soliven, B., Kennedy, T. E., & Antel, J. P. (2010). Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. American Journal of Pathology, 176, 2682–2694.
57. 2-induced apoptosis in endothelial cells. Biochemical and Biophysical Research Communications, 368, 852–857.
58. Mueller, S., Millonig, G., & Waite, G. N. (2009). The GOX/CAT system: A novel enzymatic method to independently control hydrogen peroxide and hypoxia in cell culture. Advances in Medical Sciences, 54, 121–135.
59. 2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertility and Sterility, 98, 1001–1008.
60. Neubauer, H. A., & Pitson, S. M. (2013). Roles, regulation and inhibitors of sphingosine kinase 2. FEBS Journal, 280, 5317–5336.
61. Noda, H., Takeuchi, H., Mizuno, T., & Suzumura, A. (2013). Fingolimod phosphate promotes the neuroprotective effects of microglia. Journal of Neuroimmunology, 256, 13–18.
62. O'Sullivan, C., & Dev, K. K. (2015). Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. Journal of Cell Science, 128, 3878–3887.
63. O'Sullivan, C., Schubart, A., Mir, A. K., & Dev, K. K. (2016). The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures. Journal of Neuroinflammation, 13, 31–45.
64. Ozgen, N., Guo, J., Gertsberg, Z., Danilo, P. Jr., Rosen, M. R., & Steinberg, S. F. (2009). Reactive oxygen species decrease cAMP response element binding protein expression in cardiomyocytes via a protein kinase D1-dependent mechanism that does not require Ser133 phosphorylation. Molecular Pharmacology, 76, 896–902.
65. Pathipati, P., Muller, S., Jiang, X., & Ferriero, D. (2013). Phenotype and secretory responses to oxidative stress in microglia. Developmental Neuroscience, 35, 241–254.
66. Pchejetski, D., Kunduzova, O., Dayon, A., Calise, D., Seguelas, M. H., Leducq, N., … Cuvillier, O. (2007). Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circulation Research, 100, 41–49.
67. Perfeito, R., Pereira, J., Oliveira, C. R., Bettencourt-Relvas, J., & Rego, A. C. (2007). Trolox protection of myelin membrane in hydrogen peroxide-treated mature oligodendrocytes. Free Radical Research, 41, 444–451.
68. Pritchard, A. J., Mir, A. K., & Dev, K. K. (2014). Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures. PLoS One, 9, 1–10.
69. Pyne, N. J., & Pyne, S. (2010). Sphingosine 1-phosphate and cancer. Nature Reviews Cancer, 10, 489–503.
70. Pyszko, J., & Strosznajder, J. B. (2014). Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells. Molecular Neurobiology, 50, 38–48.
71. Rudrabhatla, P. (2014). Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases. Journal of Alzheimer's Disease, 41, 671–684.
72. Rutkowska, A., Preuss, I., Gessier, F., Sailer, A. W., & Dev, K. K. (2015). EBI2 regulates intracellular signaling and migration in human astrocyte. Glia, 63, 341–351.
73. Safarian, F., Khallaghi, B., Ahmadiani, A., & Dargahi, L. (2014). Activation of S1P receptor regulates PI3K/Akt/FoxO3a pathway in response to oxidative stress in PC12 cells. Journal of Molecular Neuroscience, 56, 177–187.
74. Schirmer, L., Antel, J. P., Bruck, W., & Stadelmann, C. (2011). Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathology, 21, 428–440.
75. Schreck, R., Rieber, P., & Baeuerle, P. A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO Journal, 10, 2247–2258.
76. Sheridan, G. K., & Dev, K. K. (2012). S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia, 60, 382–392.
77. 2 generation: Redox signaling and oxidative stress. Journal of Biological Chemistry, 289, 8735–8741.
78. Sinha, K., Das, J., Pal, P. B., & Sil, P. C. (2013). Oxidative stress: The mitochondria-dependent and mitochondria-independent pathways of apoptosis. Archives of Toxicology, 87, 1157–1180.
79. 2: A quantitative comparison between continuous low-dose and one-time high-dose treatments. Free Radical Biology and Medicine, 60, 325–335.
80. Tschopp, J., & Schroder, K. (2010). NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nature Reviews Immunology, 10, 210–215.
81. Tsunoda, I., & Fujinami, R. S. (2002). Inside-out versus outside-in models for virus induced demyelination: Axonal damage triggering demyelination. Springer Seminars in Immunopathology, 24, 105–125.
82. Ushio-Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., & Griendling, K. K. (1999). Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. Journal of Biological Chemistry, 274, 22699–22704.
83. Van Brocklyn, J. R., & Williams, J. B. (2012). The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: Oxidative stress and the seesaw of cell survival and death. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 163, 26–36.
84. van Echten-Deckert, G., Hagen-Euteneuer, N., Karaca, I., & Walter, J. (2014). Sphingosine-1-phosphate: Boon and bane for the brain. Cellular Physiology and Biochemistry, 34, 148–157.
85. Veal, E. A., Day, A. M., & Morgan, B. A. (2007). Hydrogen peroxide sensing and signaling. Molecular Cell, 26, 1–14.
86. Wang, X., Wang, W., Li, L., Perry, G., Lee, H. G., & Zhu, X. (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochimica et Biophysica Acta, 1842, 1240–1247.
87. Zipp, F., & Aktas, O. (2006). The brain as a target of inflammation: Common pathways link inflammatory and neurodegenerative diseases. Trends in Neuroscience, 29, 518–527.